Gu, F., Zhang, Y., Liu, Y., Hong, X., Liang, J., Tong, F., . . . Liu, L. (2016). Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapy. J Hematol Oncol.

Gu, Fei-fei, Yong Zhang, Yang-yang Liu, Xiao-hua Hong, Jin-yan Liang, Fan Tong, Jing-song Yang, och Li Liu. "Lung Adenocarcinoma Harboring Concomitant SPTBN1-ALK Fusion, C-Met Overexpression, and HER-2 Amplification With Inherent Resistance to Crizotinib, Chemotherapy, and Radiotherapy." J Hematol Oncol 2016.

Gu, Fei-fei, et al. "Lung Adenocarcinoma Harboring Concomitant SPTBN1-ALK Fusion, C-Met Overexpression, and HER-2 Amplification With Inherent Resistance to Crizotinib, Chemotherapy, and Radiotherapy." J Hematol Oncol 2016.